SCHEMBL6176133

SCHEMBL6176133

CC(c1ccnc(NS(=O)(=O)c2ccccc2)c1)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
SLC40A1 Q9NP59 1/20 0.39
FFAR4 Q5NUL3 1/20 0.38
CCR9 P51686 3/20 0.37
ALDH1A1 P00352 1/20 0.35
GSK3B P49841 2/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
POLB P06746 1/20 0.35
ATP1A1 P05023 1/20 0.35
ATP1B1 P05026 1/20 0.35
ATP1A3 P13637 1/20 0.35
ATP1B2 P14415 1/20 0.35
ATP1A2 P50993 1/20 0.35
ATP1B3 P54709 1/20 0.35
FXYD2 P54710 1/20 0.35
ATP1A4 Q13733 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173153 0.89 LMNA (0.41) LMNASMN1; SMN2ALDH1A1GSK3BPOLB
SCHEMBL6169400 0.89 LMNA (0.38) LMNAPOLBGPR139
SCHEMBL6175979 0.87 LMNA (0.37) LMNAFFAR4POLBGPR139
SCHEMBL6172754 0.87 IGF1R (0.41) LMNAKDM4ESMN1; SMN2HTTKMT2A
SCHEMBL6175038 0.87 LMNA (0.38) LMNAKDM4EHTTALDH1A1ATP1A1
SCHEMBL6173184 0.87 LMNA (0.36) LMNAFFAR4POLBGPR139
SCHEMBL6172084 0.85 LMNA (0.40) LMNAPOLBATP1A1ATP1B1ATP1A3
SCHEMBL6173730 0.83 IDH1 (0.42) LMNAKMT2A
SCHEMBL6171770 0.83 LMNA (0.43) LMNAATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL6177220 0.82 LMNA (0.40) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed